ArthroCare (ARTC) Reports In-Line Q2 EPS of 34c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $10.03 --0%
Financial Fact:
Cost of product sales: 28.44M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Cost of product sales: 28.44M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q2 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $91.3 million versus the consensus estimate of $92.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Rithm Capital Corp. (RITM) Tops Q3 EPS by 6c
- Autoliv (ALV) Misses Q3 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
